Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thanh Pham

Optometrist Tacoma, WA Doctor of Optometry

NPI 1356357206 CMS profile 743543

2219 S 37Th St, Tacoma, WA 98409

Open in the dashboard

General payments

$10,086

123 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thanh Pham of Tacoma, WA is reported in the CMS Open Payments database as having received $10,086 across 123 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,122 15
2024 General $5,746 35
2023 General $780 15
2022 General $584 17
2021 General $433 14
2020 General $976 13
2019 General $445 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thanh Pham
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Thanh Pham were reported at $1,122. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Thanh Pham Optometrist median Middle half National median
2019 $445 $159 $67–$371 $163
2020 $976 $72 $29–$165 $114
2021 $433 $125 $46–$292 $132
2022 $584 $162 $66–$374 $149
2023 $780 $177 $72–$406 $160
2024 $5,746 $188 $77–$427 $164
2025 $1,122 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $3,716 62 payments
  2. Johnson & Johnson Vision Care, Inc. $2,664 25 payments
  3. Bausch & Lomb Americas Inc. $1,886 15 payments
  4. CooperVision Inc. $1,320 13 payments
  5. Glaukos Corporation $277 2 payments
  6. Mallinckrodt Hospital Products Inc. $92 1 payment
  7. Sun Pharmaceutical Industries Inc. $46 1 payment
  8. Bausch & Lomb, a division of Bausch Health US, LLC $24 1 payment
  9. Allergan Inc. $24 1 payment
  10. Carl Zeiss Meditec AG $19 1 payment
  11. Other $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,524 108 payments
  2. Travel and Lodging $4,518 12 payments
  3. Gift $37 2 payments
  4. Education $7 1 payment
Products named General payments · program years 2019–2025
  1. Acuvue $2,500 21 payments
  2. Multiple Brands Contact Lens $784 5 payments
  3. Precision 1 $710 17 payments
  4. TOTAL30 $636 17 payments
  5. DAILIES TOTAL1 $472 8 payments
  6. MyDay Contact Lens $443 7 payments
  7. Clareon $328 2 payments
  8. INFUSE $324 5 payments
  9. DAILIES $179 10 payments
  10. Photrexa Viscous and Photrexa $155 1 payment
  11. Other $1,063 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

123 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record